RIVANNA

01/20/2026

Reflecting on an 🌟 energizing JP Morgan Healthcare Week in San Francisco: RESI JPM is Life Science Nation's premier investor and external innovation partnering event, where Will Mauldin & Delphine Le Roux had the opportunity to participate in high-energy discussions with investors exploring the future of medtech.

Organizations like MedTech Innovator and AdvaMed play such a critical role in helping emerging medtech companies grow and thrive. We're grateful for the doors they've opened and the community they've built.

Thank you to our incredible RIVANNA team, whose dedication makes moments like this possible. 🚀

01/20/2026

The United States cesarean delivery rate is 32%, representing around 1.2 million procedures each year. For anesthesiology providers, this statistic translates to nearly 1.2 million opportunities where neuraxial anesthesia placement directly impacts patient comfort, procedure efficiency, and clinical outcomes.
Regional anesthesia forms the foundation of cesarean anesthesia care, offering advantages over general anesthesia that may include reduced maternal risk, improved pain control, and enhanced early bonding opportunities. However, these benefits depend fundamentally on accurate placement.
First-attempt success matters. Each additional needle pass may increase patient discomfort, extend procedure time, and raise the risk of complications, including post-dural puncture headache (PDPH). In anatomically complex cases — patients with obesity, scoliosis, or prior spinal surgery — landmark identification through palpation alone may become unreliable.
Pre-procedural ultrasound imaging helps address this challenge by providing anatomical visualization before needle insertion. Research demonstrates that ultrasound guidance can reduce placement failures and improve first-attempt success compared to landmark-based techniques alone.
When nearly one in three births requires cesarean delivery, technologies that enhance neuraxial precision may support better outcomes.
🔔 Follow RIVANNA for insights on obstetric anesthesia innovation.

01/12/2026

We’re heading to RESI JPM 2026!

Will Mauldin, PhD, Co-founder & CEO of RIVANNA, and Delphine Le Roux, PhD, PMP, Senior Director of Market Access & Strategic Partnerships, will be attending to meet with investors and strategic partners during JPM week.

RIVANNA develops AI-guided, radiation-free ultrasound platforms that address persistent gaps in point-of-care imaging, with a focus on advanced spinal and musculoskeletal applications. Our commercial-stage technology platform supports real-time procedural guidance and rapid bedside assessment—designed to improve clinical workflows, expand access, and scale across diverse care settings.

Backed by clinically grounded development, a strong IP foundation, and substantial non-dilutive support from U.S. government partners, we are advancing a portfolio positioned for partnership-driven commercialization.

If you’re attending RESI JPM and exploring strategic partnerships, investment opportunities, or platform technologies in medical imaging and diagnostics, we’d welcome the conversation.

01/08/2026

With more than three decades in obstetric anesthesia, Dr. Steven Garber has seen technology transform how clinicians deliver care. Yet few innovations have inspired him like RIVANNA’s Accuro 3S. After serving as an early adopter and clinical collaborator, Dr. Garber calls the system’s AI-enhanced, hands-free ultrasound and live needle tracking “a true game-changer” for challenging epidurals.

Accuro 3S is designed to help anesthesiologists identify anatomy, track the needle in real time, and approach each case with greater confidence, particularly in patients with high BMI or complex spines. For Dr. Garber, this evolution isn’t about replacing skill; it’s about augmenting it. “We’re going to be safer, more efficient, and more precise,” he says. “It’s an exciting time to be an obstetric anesthesiologist.”

🔔 Follow us to hear from more experts like Dr. Garber



https://rivannamedical.com/advancing-obstetric-anesthesia-dr-steven-garber-on-the-real-world-power-of-accuro-3s/

Obstetric anesthesiologist Dr. Steven Garber shares how the AI-powered Accuro 3S can enhance epidural precision, efficiency, and patient safety.

01/07/2026

From NASDAQ Tower in Times Square to research symposia and innovation showcases across the country, 2025 was a year of connection, collaboration, and clinical impact. RIVANNA connected with clinicians, researchers, and innovators at conferences like Innovator, Society of Anesthesiologists, and for Obstetric Anesthesia and Perinatology, advancing ultrasound-guided neuraxial anesthesia and united by a shared mission: elevating standards of care through precision imaging. Watch our 2025 year-in-review and see a few highlights that defined our commitment to excellence in innovation.

▶️ Watch the full video to see RIVANNA’s 2025 year in review.

12/23/2025

Neuraxial access disparities persist across healthcare systems, shaped by factors that vary dramatically by region and resource level.

- In low-resource settings, perioperative anesthesia-related mortality remains high. Studies from Sub-Saharan Africa demonstrate that neuraxial anesthesia can offer lower mortality risk compared to general anesthesia.

- In well-resourced countries, racial and ethnic disparities can affect who receives neuraxial techniques, with minoritized patients consistently less likely to benefit from these procedures despite documented advantages.

The roots of these anesthesia equity challenges are multifaceted. Training infrastructure, equipment availability, and systems-level factors all play a role. Providers in resource-limited areas often work with minimal supervision and basic equipment. Communication gaps and institutional practices can perpetuate unequal access even where resources exist.

Thankfully, solutions are emerging. Enhanced Recovery After Surgery (ERAS) pathways can help standardize care delivery. Affordable ultrasound technology reaches more diverse environments. Targeted training programs can focus on techniques proven safest for common procedures.

Where these strategies take hold, anesthesia equity can improve — and underserved populations stand to benefit.

🔁 Share to support equitable healthcare access.
🔔 Follow us for more updates on anesthesia training and technology.

12/22/2025

Preventative strategies and AI-assisted ultrasound are helping reduce procedural risk and evolve best practices.

👉 Download the complete report: https://tinyurl.com/4pcjcc2x

12/19/2025

More than 40% of U.S. adults are now classified as obese, and that reality is reshaping how clinicians approach complex procedures.

In high-BMI patients, traditional palpation can fall short, creating new challenges around precision, efficiency, and patient comfort. As a result, healthcare teams are increasingly turning to technology-driven solutions to support procedural excellence.

One emerging approach gaining momentum: AI-assisted ultrasound for neuraxial care—helping clinicians visualize anatomy more clearly, adapt to patient variability, and elevate the standard of care.

📘 Read the full report to see how AI-enabled imaging is influencing clinical practice and decision-making.

👉 Download here: https://tinyurl.com/4pcjcc2x

12/18/2025

Neuraxial anesthesia techniques vary significantly across international healthcare systems, shaped by local training, available technology, and clinical culture. These variations can influence patient outcomes, complication rates, and procedural success — and reveal pathways for innovation to bridge performance gaps worldwide.

🔔 Follow us for more updates on neuraxial anesthesia practices, training, and technology.

Global neuraxial practices vary by region, affecting patient outcomes. Explore how training, technology, and culture shape international anesthesia standards.

12/18/2025

Regional differences in neuraxial anesthesia training and practice have long shaped how care is delivered worldwide. What works as standard protocol in one country may be considered an advanced technique in another, creating gaps in consistency and safety benchmarks.

Collaborative anesthesia research is addressing these disparities. A 2021 ASRA-ESRA Delphi Consensus Study brought together 60 expert collaborators to develop cross-border anesthesia terminology standards, supporting a common language across institutions and training programs.

Joint efforts between the European Society of Anaesthesiology and Intensive Care, the European Society of Regional Anaesthesia, and the American Society of Regional Anesthesia and Pain Medicine have produced global neuraxial guidelines on critical safety topics, achieving consensus on evidence-based recommendations through systematic review and expert agreement.

These collaborative efforts are establishing:

- Standardized terminology that reduces miscommunication among practitioners worldwide
- Multi-institutional research networks sharing outcome data across continents
- Open-access guidelines making evidence-based recommendations broadly available to diverse healthcare settings

As these initiatives expand, the foundation for consistent, high-quality neuraxial care becomes accessible to providers in more healthcare systems globally.

🔁 Share to support evidence-based global standards.
🔔 Follow us for more updates on neuraxial innovation.

12/17/2025

We’re proud to share that the Accuro 3S Needle Guide Kit has received FDA clearance. This milestone reflects the dedicated work of our team and clinical collaborators, as well as our continued focus on enhancing clinician workflows and patient outcomes.

Full release: tinyurl.com/22j8r6zx

12/12/2025

🌟 Now Extended: Save 20% on Accuro through December. It’s an ideal time to evaluate tools that enhance precision and promote smoother neuraxial workflows. 👉 Click the link for year-end savings on Accuro. https://tinyurl.com/mt5dephf

While ultrasound has long been recommended for epidural placement in obstetrics, its routine use for neuraxial blocks in the obstetric unit remains limited. Common barriers include the lack of a dedicated ultrasound machine, space constraints, cost, learning curves, and concerns about added procedure time; this is where Accuro can help—and we’re extending a 20% end-of-year savings opportunity for teams exploring a more streamlined approach.

A randomized trial in 80 obese parturients undergoing cesarean delivery illustrates the impact of imaging support. When clinicians used the AI-assisted Accuro system for combined spinal-epidural anesthesia, the results showed:

✅ ≈81% higher first-insertion success (72.5% vs 40.0%)
✅ ≈45% fewer needle redirections (40% vs 72.5%)
✅ ≈83% reduction in paresthesia (7.5% vs 45.0%)
✅ No meaningful difference in procedure duration or number of skin punctures

These findings highlight how technology can help support technically challenging neuraxial placements and provide a more predictable experience for clinicians and patients alike.

Source: Ni X et al., J Anesth. 2021;35:475–482.